Skip to main content

Blueprint for Access to Innovative Healthcare Episode 2: Screening

By: 3BL Media
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SOURCE: Takeda

DESCRIPTION:

Takeda’s flagship Access to Medicines initiative, the Blueprint for Innovative Healthcare Access program, works with a consortium of public and private partners sharing resources and responsibility, each bringing specific strengths and expertise to address rising Non-Communicable Diseases (NCDs) challenges in underserved communities. Meet the people who are living and breathing the Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya.

Tweet me: Meet the people who are living and breathing @Takeda's Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya. https://bit.ly/3w5qELy

KEYWORDS: takeda, Blueprint for Access to Innovative Healthcare, NYSE: TAK

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.95
-3.79 (-1.42%)
AAPL  346.85
-5.60 (-1.59%)
AMD  484.29
-45.85 (-8.65%)
BAC  48.23
-0.67 (-1.38%)
GOOG  280.10
+0.90 (0.32%)
META  607.66
-8.72 (-1.41%)
MSFT  505.59
-2.70 (-0.53%)
NVDA  148.81
-2.15 (-1.42%)
ORCL  111.72
-2.17 (-1.90%)
TSLA  373.19
-10.53 (-2.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.